• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: CD45RO-Positive Memory T Cell Density in the Tumoral Core and Invasive Margin as an Immune-Related Prognostic Marker in Esophageal Squamous Cell Carcinoma.

作者信息

Noma Toshiki, Makino Tomoki, Doki Yuichiro

机构信息

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan.

Department of Gastroenterological Surgery, Toyonaka Municipal Hospital, Toyonaka City, Osaka, Japan.

出版信息

Ann Surg Oncol. 2025 Apr;32(4):2702-2703. doi: 10.1245/s10434-024-16754-z. Epub 2025 Jan 6.

DOI:10.1245/s10434-024-16754-z
PMID:39762533
Abstract
摘要

相似文献

1
ASO Author Reflections: CD45RO-Positive Memory T Cell Density in the Tumoral Core and Invasive Margin as an Immune-Related Prognostic Marker in Esophageal Squamous Cell Carcinoma.ASO作者反思：肿瘤核心和浸润边缘中CD45RO阳性记忆T细胞密度作为食管鳞状细胞癌的免疫相关预后标志物
Ann Surg Oncol. 2025 Apr;32(4):2702-2703. doi: 10.1245/s10434-024-16754-z. Epub 2025 Jan 6.
2
CD45RO-Positive Memory T-Cell Density in the Tumoral Core and Invasive Margin Predict Long-Term Survival in Esophageal Squamous Cell Carcinoma.肿瘤核心和浸润边缘的CD45RO阳性记忆T细胞密度可预测食管鳞状细胞癌的长期生存。
Ann Surg Oncol. 2025 Mar;32(3):1953-1962. doi: 10.1245/s10434-024-16530-z. Epub 2024 Dec 5.
3
ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.ASO作者反思：淋巴结比率是微创食管切除术后食管鳞状细胞癌的独立预后因素。
Ann Surg Oncol. 2021 Aug;28(8):4529. doi: 10.1245/s10434-020-09452-z. Epub 2021 Jan 5.
4
CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.CD45RO+TILs：喉鳞癌结局的细胞生物标志物。
Braz J Otorhinolaryngol. 2022 Nov-Dec;88 Suppl 4(Suppl 4):S133-S142. doi: 10.1016/j.bjorl.2022.09.007. Epub 2022 Oct 14.
5
ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.ASO作者反思：壁内转移作为食管鳞状细胞癌的不良预后因素
Ann Surg Oncol. 2023 Aug;30(8):5203-5204. doi: 10.1245/s10434-023-13509-0. Epub 2023 Jun 7.
6
ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.ASO作者反思：凝血指标对食管鳞状细胞癌患者的预后作用
Ann Surg Oncol. 2021 Dec;28(13):8462-8463. doi: 10.1245/s10434-021-10267-9. Epub 2021 Jun 9.
7
CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.CD45RO(+)记忆性T淋巴细胞——鳞状非小细胞肺癌TNM免疫评分的候选标志物
Neoplasia. 2015 Nov;17(11):839-48. doi: 10.1016/j.neo.2015.11.004.
8
ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.ASO作者反思：新辅助治疗后激肽释放酶相关肽酶13诱导在食管鳞状细胞癌中的预后意义
Ann Surg Oncol. 2024 Jan;31(1):243-244. doi: 10.1245/s10434-023-14461-9. Epub 2023 Oct 18.
9
ASO Author Reflections: Endoscopic Ultrasonography for Determining Clinical T Classification for Esophageal Squamous Cell Carcinoma.ASO作者反思：内镜超声检查在确定食管鳞状细胞癌临床T分期中的应用
Ann Surg Oncol. 2018 Dec;25(Suppl 3):956-957. doi: 10.1245/s10434-018-6914-7. Epub 2018 Nov 19.
10
ASO Author Reflections: Evaluating NPTXR as a Prognostic Biomarker and Therapeutic Target in Esophageal Squamous Cell Carcinoma.ASO作者反思：评估NPTXR作为食管鳞状细胞癌的预后生物标志物和治疗靶点
Ann Surg Oncol. 2024 Sep;31(9):5765. doi: 10.1245/s10434-024-15425-3. Epub 2024 May 15.

本文引用的文献

1
CD45RO-Positive Memory T-Cell Density in the Tumoral Core and Invasive Margin Predict Long-Term Survival in Esophageal Squamous Cell Carcinoma.肿瘤核心和浸润边缘的CD45RO阳性记忆T细胞密度可预测食管鳞状细胞癌的长期生存。
Ann Surg Oncol. 2025 Mar;32(3):1953-1962. doi: 10.1245/s10434-024-16530-z. Epub 2024 Dec 5.
2
Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer.免疫评分特征在手术标本和预处理活检中的肿瘤浸润淋巴细胞可预测食管癌的治疗疗效和生存。
Ann Surg. 2023 Mar 1;277(3):e528-e537. doi: 10.1097/SLA.0000000000005104. Epub 2021 Jul 29.
3
Lymph Node Response to Neoadjuvant Chemotherapy as an Independent Prognostic Factor in Metastatic Esophageal Cancer.
新辅助化疗后淋巴结反应作为转移性食管癌的独立预后因素。
Ann Surg. 2021 Jun 1;273(6):1141-1149. doi: 10.1097/SLA.0000000000003445.
4
Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer.代谢肿瘤体积变化可预测局部晚期食管癌患者的长期生存和术前化疗的组织学反应。
Ann Surg. 2019 Dec;270(6):1090-1095. doi: 10.1097/SLA.0000000000002808.
5
Clinical impact of tumor-infiltrating CD45RO⁺ memory T cells on human gastric cancer.肿瘤浸润性 CD45RO+记忆 T 细胞对人类胃癌的临床影响。
Oncol Rep. 2013 May;29(5):1756-62. doi: 10.3892/or.2013.2302. Epub 2013 Feb 22.